A citation-based method for searching scientific literature

R R Laborde, M M Patnaik, T L Lasho, C M Finke, C A Hanson, R A Knudson, R P Ketterling, A Pardanani, A Tefferi. Leukemia 2013
Times Cited: 68







List of co-cited articles
582 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.
F Damm, R Itzykson, O Kosmider, N Droin, A Renneville, V Chesnais, V Gelsi-Boyer, S de Botton, N Vey, C Preudhomme,[...]. Leukemia 2013
86
58

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.
Rocco Piazza, Simona Valletta, Nils Winkelmann, Sara Redaelli, Roberta Spinelli, Alessandra Pirola, Laura Antolini, Luca Mologni, Carla Donadoni, Elli Papaemmanuil,[...]. Nat Genet 2013
242
57

Prognostic score including gene mutations in chronic myelomonocytic leukemia.
Raphaël Itzykson, Olivier Kosmider, Aline Renneville, Véronique Gelsi-Boyer, Manja Meggendorfer, Margot Morabito, Céline Berthon, Lionel Adès, Pierre Fenaux, Odile Beyne-Rauzy,[...]. J Clin Oncol 2013
337
55

Somatic SETBP1 mutations in myeloid malignancies.
Hideki Makishima, Kenichi Yoshida, Nhu Nguyen, Bartlomiej Przychodzen, Masashi Sanada, Yusuke Okuno, Kwok Peng Ng, Kristbjorn O Gudmundsson, Bandana A Vishwakarma, Andres Jerez,[...]. Nat Genet 2013
171
48

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients.
M M Patnaik, R Itzykson, T L Lasho, O Kosmider, C M Finke, C A Hanson, R A Knudson, R P Ketterling, A Tefferi, E Solary. Leukemia 2014
164
39

Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes.
M M Patnaik, E Padron, R R LaBorde, T L Lasho, C M Finke, C A Hanson, J M Hodnefield, R A Knudson, R P Ketterling, A Al-kali,[...]. Leukemia 2013
132
38

SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
M Meggendorfer, U Bacher, T Alpermann, C Haferlach, W Kern, C Gambacorti-Passerini, T Haferlach, S Schnittger. Leukemia 2013
112
38

SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML).
Manja Meggendorfer, Andreas Roller, Torsten Haferlach, Christiane Eder, Frank Dicker, Vera Grossmann, Alexander Kohlmann, Tamara Alpermann, Kenichi Yoshida, Seishi Ogawa,[...]. Blood 2012
206
38

Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
Julia E Maxson, Jason Gotlib, Daniel A Pollyea, Angela G Fleischman, Anupriya Agarwal, Christopher A Eide, Daniel Bottomly, Beth Wilmot, Shannon K McWeeney, Cristina E Tognon,[...]. N Engl J Med 2013
319
33

CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
A Pardanani, T L Lasho, R R Laborde, M Elliott, C A Hanson, R A Knudson, R P Ketterling, J E Maxson, J W Tyner, A Tefferi. Leukemia 2013
158
32

SETBP1 mutation analysis in 944 patients with MDS and AML.
F Thol, K J Suchanek, C Koenecke, M Stadler, U Platzbecker, C Thiede, T Schroeder, G Kobbe, S Kade, P Löffeld,[...]. Leukemia 2013
53
39

Cytogenetic risk stratification in chronic myelomonocytic leukemia.
Esperanza Such, José Cervera, Dolors Costa, Francesc Solé, Teresa Vallespí, Elisa Luño, Rosa Collado, María J Calasanz, Jesús M Hernández-Rivas, Juan C Cigudosa,[...]. Haematologica 2011
166
30

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients.
Francesco Onida, Hagop M Kantarjian, Terry L Smith, Greg Ball, Michael J Keating, Elihu H Estey, Armand B Glassman, Maher Albitar, Monica I Kwari, Miloslav Beran. Blood 2002
260
30

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
30

Clonal architecture of chronic myelomonocytic leukemias.
Raphaël Itzykson, Olivier Kosmider, Aline Renneville, Margot Morabito, Claude Preudhomme, Céline Berthon, Lionel Adès, Pierre Fenaux, Uwe Platzbecker, Olivier Gagey,[...]. Blood 2013
174
29

Frequent pathway mutations of splicing machinery in myelodysplasia.
Kenichi Yoshida, Masashi Sanada, Yuichi Shiraishi, Daniel Nowak, Yasunobu Nagata, Ryo Yamamoto, Yusuke Sato, Aiko Sato-Otsubo, Ayana Kon, Masao Nagasaki,[...]. Nature 2011
27

Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1.
Alexander Kohlmann, Vera Grossmann, Hans-Ulrich Klein, Sonja Schindela, Tamara Weiss, Beray Kazak, Frank Dicker, Susanne Schnittger, Martin Dugas, Wolfgang Kern,[...]. J Clin Oncol 2010
230
27

Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia.
Esperanza Such, Ulrich Germing, Luca Malcovati, José Cervera, Andrea Kuendgen, Matteo G Della Porta, Benet Nomdedeu, Leonor Arenillas, Elisa Luño, Blanca Xicoy,[...]. Blood 2013
169
27

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
James W Vardiman, Jüergen Thiele, Daniel A Arber, Richard D Brunning, Michael J Borowitz, Anna Porwit, Nancy Lee Harris, Michelle M Le Beau, Eva Hellström-Lindberg, Ayalew Tefferi,[...]. Blood 2009
26

Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms.
O Abdel-Wahab, A Pardanani, J Patel, M Wadleigh, T Lasho, A Heguy, M Beran, D G Gilliland, R L Levine, A Tefferi. Leukemia 2011
164
25

De novo mutations of SETBP1 cause Schinzel-Giedion syndrome.
Alexander Hoischen, Bregje W M van Bon, Christian Gilissen, Peer Arts, Bart van Lier, Marloes Steehouwer, Petra de Vries, Rick de Reuver, Nienke Wieskamp, Geert Mortier,[...]. Nat Genet 2010
321
23


Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
Véronique Gelsi-Boyer, Virginie Trouplin, José Adélaïde, Julien Bonansea, Nathalie Cervera, Nadine Carbuccia, Arnaud Lagarde, Thomas Prebet, Meyer Nezri, Danielle Sainty,[...]. Br J Haematol 2009
420
23

Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review.
Mrinal M Patnaik, Sameer A Parikh, Curtis A Hanson, Ayalew Tefferi. Br J Haematol 2014
66
24

SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia.
Ion Cristóbal, Francisco J Blanco, Laura Garcia-Orti, Nerea Marcotegui, Carmen Vicente, José Rifon, Francisco J Novo, Eva Bandres, María J Calasanz, Carmelo Bernabeu,[...]. Blood 2010
107
22

Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study.
Emnet A Wassie, Raphael Itzykson, Terra L Lasho, Olivier Kosmider, Christy M Finke, Curtis A Hanson, Rhett P Ketterling, Eric Solary, Ayalew Tefferi, Mrinal M Patnaik. Am J Hematol 2014
90
22

Clinical effect of point mutations in myelodysplastic syndromes.
Rafael Bejar, Kristen Stevenson, Omar Abdel-Wahab, Naomi Galili, Björn Nilsson, Guillermo Garcia-Manero, Hagop Kantarjian, Azra Raza, Ross L Levine, Donna Neuberg,[...]. N Engl J Med 2011
20

Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine.
Lionel Adès, Mikkael A Sekeres, Alice Wolfromm, Melissa L Teichman, Ramon V Tiu, Raphael Itzykson, Jaroslaw P Maciejewski, Francois Dreyfus, Alan F List, Pierre Fenaux,[...]. Leuk Res 2013
79
20

Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities.
Hesham Eissa, Ted A Gooley, Mohamed L Sorror, Franchesca Nguyen, Bart L Scott, Kristine Doney, Keith R Loeb, Paul J Martin, John M Pagel, Jerry P Radich,[...]. Biol Blood Marrow Transplant 2011
80
20

Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance.
Mrinal M Patnaik, Terra L Lasho, Christy M Finke, Curtis A Hanson, Janice M Hodnefield, Ryan A Knudson, Rhett P Ketterling, Animesh Pardanani, Ayalew Tefferi. Am J Hematol 2013
100
20

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.
Anna M Jankowska, Hideki Makishima, Ramon V Tiu, Hadrian Szpurka, Yun Huang, Fabiola Traina, Valeria Visconte, Yuka Sugimoto, Courtney Prince, Christine O'Keefe,[...]. Blood 2011
236
20

Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia.
Hirotoshi Sakaguchi, Yusuke Okuno, Hideki Muramatsu, Kenichi Yoshida, Yuichi Shiraishi, Mariko Takahashi, Ayana Kon, Masashi Sanada, Kenichi Chiba, Hiroko Tanaka,[...]. Nat Genet 2013
149
19

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System.
Hagop Kantarjian, Susan O'Brien, Farhad Ravandi, Jorge Cortes, Jianqin Shan, John M Bennett, Alan List, Pierre Fenaux, Guillermo Sanz, Jean-Pierre Issa,[...]. Cancer 2008
342
19

Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire.
Sophie Park, Myriam Labopin, Ibrahim Yakoub-Agha, Jacques Delaunay, Nathalie Dhedin, Eric Deconinck, Mauricette Michallet, Marie Robin, Thierry De Revel, Marc Bernard,[...]. Eur J Haematol 2013
45
28

ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.
Véronique Gelsi-Boyer, Virginie Trouplin, Julien Roquain, José Adélaïde, Nadine Carbuccia, Benjamin Esterni, Pascal Finetti, Anne Murati, Christine Arnoulet, Hacène Zerazhi,[...]. Br J Haematol 2010
158
19

Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia.
Ahmed Aribi, Gautam Borthakur, Farhad Ravandi, Jianqin Shan, Jan Davisson, Jorge Cortes, Hagop Kantarjian. Cancer 2007
90
19

Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial.
Thorsten Braun, Raphael Itzykson, Aline Renneville, Benoit de Renzis, François Dreyfus, Kamel Laribi, Krimo Bouabdallah, Norbert Vey, Andrea Toma, Christian Recher,[...]. Blood 2011
146
19

GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia.
Eric Padron, Jeffrey S Painter, Sateesh Kunigal, Adam W Mailloux, Kathy McGraw, Jessica M McDaniel, Eunhee Kim, Christopher Bebbington, Mark Baer, Geoffrey Yarranton,[...]. Blood 2013
101
19

ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.
Omar Abdel-Wahab, Mazhar Adli, Lindsay M LaFave, Jie Gao, Todd Hricik, Alan H Shih, Suveg Pandey, Jay P Patel, Young Rock Chung, Richard Koche,[...]. Cancer Cell 2012
367
19

International scoring system for evaluating prognosis in myelodysplastic syndromes.
P Greenberg, C Cox, M M LeBeau, P Fenaux, P Morel, G Sanz, M Sanz, T Vallespi, T Hamblin, D Oscier,[...]. Blood 1997
17


Activity of azacitidine in chronic myelomonocytic leukemia.
Rubens Costa, Haifaa Abdulhaq, Bushra Haq, Richard K Shadduck, Joan Latsko, Mazen Zenati, Folefac D Atem, James M Rossetti, Entezam A Sahovic, John Lister. Cancer 2011
98
17

Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML).
P W Wijermans, B Rüter, M R Baer, J L Slack, H I Saba, M Lübbert. Leuk Res 2008
89
17

RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
Clara Ricci, Elisa Fermo, Stefania Corti, Mauro Molteni, Alessio Faricciotti, Agostino Cortelezzi, Giorgio Lambertenghi Deliliers, Miloslav Beran, Francesco Onida. Clin Cancer Res 2010
88
17

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.
Marta Fernandez-Mercado, Andrea Pellagatti, Cristina Di Genua, Maria Jose Larrayoz, Nils Winkelmann, Paula Aranaz, Adam Burns, Anna Schuh, Maria Jose Calasanz, Nicholas C P Cross,[...]. Br J Haematol 2013
33
36

An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults.
Michael R Savona, Luca Malcovati, Rami Komrokji, Ramon V Tiu, Tariq I Mughal, Attilio Orazi, Jean-Jacques Kiladjian, Eric Padron, Eric Solary, Raoul Tibes,[...]. Blood 2015
98
17

Identification and characterization of SEB, a novel protein that binds to the acute undifferentiated leukemia-associated protein SET.
M Minakuchi, N Kakazu, M J Gorrin-Rivas, T Abe, T D Copeland, K Ueda, Y Adachi. Eur J Biochem 2001
58
18

Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Nicolaus Kröger, Tatjana Zabelina, Philipe Guardiola, Volker Runde, Jorge Sierra, Anja Van Biezen, Dietger Niederwieser, Axel R Zander, Theo De Witte. Br J Haematol 2002
72
16

Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value.
Alexander E Smith, Azim M Mohamedali, Austin Kulasekararaj, ZiYi Lim, Joop Gäken, Nicholas C Lea, Bartlomiej Przychodzen, Syed A Mian, Erick E Nasser, Claire Shooter,[...]. Blood 2010
176
16

Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance.
V Grossmann, A Kohlmann, C Eder, C Haferlach, W Kern, N C P Cross, T Haferlach, S Schnittger. Leukemia 2011
104
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.